Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,006 | 115,086 | 123,490 | 37,346 | 46,921 |
| Marketable Securities | 437,482 | 449,583 | 459,361 | 403,208 | 409,101 |
| Receivables | 101,462 | 76,935 | 74,228 | 59,402 | 54,354 |
| Inventories | 42,677 | 46,196 | 39,280 | 31,207 | 23,720 |
| TOTAL | $726,323 | $700,644 | $707,759 | $544,607 | $546,191 |
| Non-Current Assets | |||||
| PPE Net | 64,671 | 62,851 | 62,828 | 62,925 | 60,141 |
| Other Non-Current Assets | 24,978 | 24,242 | 24,199 | 25,403 | 30,330 |
| TOTAL | $89,649 | $87,093 | $87,027 | $88,328 | $90,471 |
| Total Assets | $815,972 | $787,737 | $794,786 | $632,935 | $636,662 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 687 | 1,098 | 1,492 | 2,467 | 2,609 |
| Accounts payable and accrued liabilities | 12,488 | 9,526 | 19,174 | 15,261 | 12,146 |
| Accrued Expenses | 26,148 | 28,870 | 30,626 | 31,278 | 23,332 |
| TOTAL | $82,692 | $69,082 | $80,117 | $71,744 | $56,690 |
| Non-Current Liabilities | |||||
| Long Term Debt | 297 | 330 | 389 | 752 | 1,411 |
| Deferred Revenues | 17,137 | 4,362 | 3,996 | 3,899 | 2,116 |
| Other Non-Current Liabilities | 250,000 | 254,281 | 254,591 | 254,895 | 255,192 |
| TOTAL | $257,244 | $261,711 | $262,232 | $263,052 | $265,557 |
| Total Liabilities | $339,936 | $330,793 | $342,349 | $334,796 | $322,247 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,566,755 | 1,558,801 | 1,551,994 | 1,535,103 | 1,523,297 |
| Common Shares | 196 | 195 | 193 | 96 | 95 |
| Retained earnings | -437,876 | -457,587 | -453,737 | -585,314 | -560,118 |
| Other shareholders' equity | -15,090 | -2,492 | 7,448 | 6,444 | 2,023 |
| TOTAL | $476,036 | $456,944 | $452,437 | $298,139 | $314,415 |
| Total Liabilities And Equity | $815,972 | $787,737 | $794,786 | $632,935 | $636,662 |